Author: admin

Bernard Arnault, chairman and CEO of LVMH, will receive the Yale Legend in Leadership Award at the Yale CEO Summit, which will take place in New York City on December 17. He was nominated by past award winners and confirmed by Yale faculty members. The award will be presented on their behalf by entrepreneur and philanthropist Ivanka Trump; Condé Nast global chief content officer and artistic director Anna Wintour; and Blackstone chairman and CEO Stephen Schwarzman. The full award ceremony will be carried live on CNBC TV and on CNBC.com.

Summit organizer Jeffrey Sonnenfeld, senior associate dean for leadership studies at the Yale School of Management, said:

“Bernard Arnault stands among the rare titans whose vision has reshaped not just business, but culture and society more broadly. His leadership illuminates the extraordinary possibilities that emerge when commercial imagination is paired with cultural vision, civic engagement, social impact, and long-term stewardship.

“Arnault is at once one of the most revered business leaders of our time and a widely admired patron of extraordinary artistic creativity. Under his stewardship, LVMH became the first European company to surpass a $500 billion valuation, transforming a constellation of independent, often family-run ‘maisons’ into a pioneering global powerhouse—without ever sacrificing their soul, heritage, or devotion to meticulous craftsmanship.

“While his commercial accomplishments speak for themselves, what makes Arnault unique as a Yale Legend in Leadership Award recipient is not simply the scale of his success, but the philosophy behind it. As the architect of the modern luxury industry, he has shown that genuine leadership in this realm is not about excess but about excellence; not about exclusivity but about enduring cultural contribution. He has elevated centuries-old traditions while embracing modern design, digital innovation, social responsibility, and global accessibility—often anticipating trends years before others even recognized them.

“Beyond the extraordinary business empire he has built, Arnault has served as a guardian of culture and a champion of human creativity. His vision gave rise to the Fondation Louis Vuitton, one of the defining architectural and artistic landmarks of this century, and his leadership helped rally global support for the restoration of Notre-Dame Cathedral after the devastating fire in 2019—just two examples of his deep civic commitment. He has also been a tireless advocate for expanding opportunities within the fashion industry for individuals from underrepresented and underserved backgrounds. From fashion to fine art to philanthropy, his impact radiates far beyond balance sheets.

“Arnault embodies the rare combination of business acumen, strategic discipline, aesthetic sensitivity, moral courage, and cultural stewardship that defines history’s most influential leaders. He has preserved and strengthened some of the world’s most treasured legacies while cultivating the next generation of creative visionaries. His legacy is one of building, nurturing, imagining, and inspiring.

For these reasons, Arnault is not only a deserving recipient of the Yale Legend in Leadership; he is a global cultural force whose imprint will endure for generations.”

Arnault has served as chairman and CEO of LVMH since 1989. Under his tenure, the group has grown to encompass over 75 distinguished houses, or brands, across six distinct sectors: wines and spirits, fashion and leather goods, perfumes and cosmetics, watches and jewelry, selective retailing, and other activities.

Key milestones of his leadership include the strategic development of “star brands” such as Louis Vuitton, Christian Dior, and Tiffany & Co., the latter of which was acquired in 2021 in one of the largest deals in luxury history. Arnault’s philosophy centers on a long-term vision that prioritizes desirability and craftsmanship over short-term volume, a strategy that has propelled LVMH to become one of the most valuable companies in the world.

Arnault began his career as an engineer at the Ferret-Savinel construction company, where he was promoted to various executive management positions before becoming chairman in 1978. He pivoted to the luxury sector in 1984 with the acquisition of the Boussac textile group, which owned Christian Dior. He is Grand-croix de la Légion d’honneur and a Commandeur in the French Ordre des Arts et des Lettres.

Yale Legend in Leadership Award

The Yale Legend in Leadership Award was created 35 years ago to honor current and former CEOs who serve as living legends to inspire chief executives across industries, sectors, and nations. Past recipients include: Jensen Huang, CEO of NVIDIA; Tim Cook, CEO of Apple; Greg Brown, chair and CEO of Motorola Solutions; Glenn Fogel, CEO of Booking Holdings; Larry Fink, chair and CEO of BlackRock; James Quincey, chair and CEO of Coca-Cola; Marc Benioff, chair and CEO of Salesforce; Mike Sievert, CEO of T-Mobile; Ajay Banga, president of the World Bank; Arvind Krishna, chair and CEO of IBM; Steven Spielberg, filmmaker and chair of Amblin Partners; Darius Adamczyk, CEO of Honeywell; Volodymyr Zelenskyy, president of Ukraine; Doug Parker, chairman of American Airlines; Albert Bourla, CEO of Pfizer; Alex Gorsky, CEO of Johnson & Johnson; Lynn Good, CEO of Duke Energy; Lisa Su, CEO of AMD; Anthony Fauci, director of the NIAID; Doug McMillon, CEO of Walmart; Arne Sorenson, CEO of Marriott International; Andrew J. Young, mayor of Atlanta (1982-1990) and ambassador to the United Nations (1977-1979); Brian C. Cornell, chair and CEO of Target Corporation; Ivan G. Seidenberg, chair and CEO of Verizon Communications; Ken Frazier, chair and CEO of Merck & Co.; Colin Powell, four-star U.S. Army general, chairman of the Joint Chiefs of Staff (1989–1993), and secretary of state (2001-2005); Janet Yellen, United States secretary of the treasury; Paul Polman, CEO of Unilever PLC; Mary T. Barra, chairman and CEO of General Motors Company; Brian Moynihan, chairman and CEO of Bank of America; David M. Rubenstein, co-founder and co-executive chairman of the Carlyle Group; Leonard S. Schleifer, president and CEO of Regeneron Pharmaceuticals; George D. Yancopoulos, president and chief scientific officer of Regeneron Pharmaceuticals; Brian Roberts, CEO of Comcast; Marillyn Hewson, CEO of Lockheed Martin; Jamie Dimon, CEO of JPMorgan Chase; and Ken Chenault, chair and CEO of American Express.

The 2025 Yale CEO Summit theme is “Is There Any Order to the New World Order? Planning Your Strategic Horizons Through the Global Haze.”

Yale CEO Summit partners and sponsors include AlixPartners, Atlas Merchant Capital, Deloitte, Evercore, Gladstone Place Partners, IBM, McKinsey & Company, Paul Weiss, Pfizer, TD Bank Group, and Yale School of Management Executive Education.

Donald Trump declared he “should be listened to” by the Federal Reserve, as he weighs candidates to lead the central bank amid an extraordinary campaign by the White House to exert greater control over its decisions.

The US president said on Friday that former Fed governor Kevin Warsh is currently top of his list to chair the central bank.

Jerome Powell, the current Fed chairperson, is scheduled to finish an eight-year stint in the role next May. He has repeatedly defied Trump’s demands for drastic cuts to interest rates, prompting the president to launch a string of public attacks.

Trump is also considering his adviser Kevin Hassett, who leads the National Economic Council, as a potential chair of the Fed.

“I think you have Kevin and Kevin. They’re both – I think the two Kevins are great,” the president told the Wall Street Journal on Friday. “I think there are a couple of other people that are great.”

He is expected to soon nominate a candidate to lead the Fed, having lambasted the central bank’s policymakers for their cautious approach to cutting rates since return to office in January – and has even tried to fire a member of the central bank’s rate-setting policy committee.

Warsh “thinks you have to lower interest rates,” Trump claimed in the interview, in line with the views he has expressed himself for months. “And so does everybody else that I’ve talked to.”

Trump argued that the next Fed chair should listen to him on the future direction of rates. “Typically, that’s not done anymore,” he acknowledged to the Wall Street Journal. “It should be done.”

“It doesn’t mean – I don’t think he should do exactly what we say,” Trump added. “But certainly we’re – I’m a smart voice and should be listened to.”

Earlier this week, the Fed cut rates by a quarter point for the third time this year. But policymakers signaled their reluctance to cut more than once next year, amid heightened uncertainty around the direction of the economy.

In a press conference on Wednesday, Powell said the Fed was trying to balance “significant downside risks” in the jobs market with inflationary pressures from Trump’s tariffs that are “pretty clear to see”.

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter 2025 financial results on Wednesday, January 28, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.

In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.

A live webcast of the call will be available on Teva’s website at: https://ir.tevapharm.com/Events-and-Presentations.

Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This Document and the presentation at the conferences may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the third quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the section captioned “Risk Factors” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries
[email protected]

Teva Investor Relations Inquiries
[email protected]